You’re on our free ad-supported tier. Upgrade to NewsNow Essentials now and get your favourite news platform, faster, slicker and ads free.You’re on our free tier. Upgrade to NewsNow Essentials now. Faster, slicker and ads free.You’re on our free tier. Upgrade and go ads free now!

Home
Hot Topics
Australia
World
Sport
Business
Entertainment
Science
Technology
Lifestyle

Johnson and Johnson
Pharmaceuticals
GSK
AstraZeneca
Novo Nordisk
Sanofi
Abbott Labs
Eli Lilly
Topics

Advertisement

Johnson and Johnson

Share

Top Latest Popular

In the last 4 hours

New AI Glasses, an AI Cybersecurity Clearinghouse, a Research Station for Missions to the Moon and Mars – News of Note for the... JD Supra 00:50

Yesterday

J&J's Innovative Medicine Unit Proves Its Resilience in Q2 Zacks 16:36 Fri, 24 Jul

This "Boring" Dividend King Is Quietly Turning Into a Growth Machine -- and Many Investors Are Missing It The Motley Fool 15:45 Fri, 24 Jul

Advertisement

Advertisement

J&J’s multiple myeloma combo cuts risk of death by 62% in Phase III study Clinical Trials Arena 11:11 Fri, 24 Jul

J&J's multiple myeloma duo aces phase 3 trial pharmaphorum 09:33 Fri, 24 Jul

Johnson And Johnson Stock And Other Defensive Dividend Picks For Uncertain Markets Simply Wall St 02:06 Fri, 24 Jul

Johnson & Johnson (JNJ) Could Be 33% Below Fair Value Following OTTAVA FDA Clearance Simply Wall St 02:06 Fri, 24 Jul

Thursday

J&J's Delays Should End $25M Asbestos Appeal, Builder Says Law360 20:49 Thu, 23 Jul

J&J Finally Has a Rival to da Vinci. 1 Number in Intuitive Surgical’s Last Quarter Says It Won’t Be Enough to Move the Needle for JNJ Stock. Barchart 20:23 Thu, 23 Jul

Federal Judge Casts Doubt on 69,000 Cases Alleging J&J Talc Caused Cancer Insurance Journal 16:52 Thu, 23 Jul

Arkansas Sues Pfizer, J&J, Others Over Drug Discount Access Bloomberg Law 15:26 Thu, 23 Jul

Judge Casts Doubt on 69,000 Cases Alleging J&J Talc Caused Cancer Insurance Claims Journal 14:47 Thu, 23 Jul

Tecvayli® + Talvey® reduced the risk of disease progression or death by 89% and the risk of death by 62% in earlier-line relapsed/refractory multiple myeloma PR Newswire (Press Release) 13:31 Thu, 23 Jul

J&J table-integrated surgical robot gets FDA approval Silicon Republic 09:44 Thu, 23 Jul

J&J Talc Plaintiffs Must Back Up Cancer Link Or Risk MDL Law360 04:42 Thu, 23 Jul

Johnson & Johnson Wins Big: Federal Judge Orders Nearly 70,000 Talc Claimants to Show Why They Shouldn't be Dismissed Law.com 00:54 Thu, 23 Jul

Advertisement

Wednesday

Why Johnson & Johnson Is Sending Intuitive Surgical (ISRG) Stock Down Today Barchart 21:39 Wed, 22 Jul

Johnson & Johnson wins FDA authorization for its robotic surgery device Cryptopolitan 18:32 Wed, 22 Jul

J&J MedTech jumps into surgical robot game as OTTAVA secures FDA nod Verdict Medical Devices 16:40 Wed, 22 Jul

Johnson & Johnson (JNJ) is Attracting Investor Attention: Here is What You Should Know Zacks 15:09 Wed, 22 Jul

Johnson & Johnson Wins FDA Authorization For Ottava Robotic Surgical System RTT News 14:34 Wed, 22 Jul

Johnson & Johnson’s robotic surgery device gets US marketing authorization BNN Bloomberg 13:50 Wed, 22 Jul

Johnson & Johnson's robotic surgery device gets US FDA marketing authorization The Economic Times 13:06 Wed, 22 Jul

Johnson & Johnson Receives FDA Market Authorization in the U.S. for its Ottava™ Robotic Surgical System Business Wire (Press Release) 12:01 Wed, 22 Jul

ACC introduces cardiogenic shock designation to improve heart attack care News-Medical.Net 05:16 Wed, 22 Jul

Tuesday

H.E. Mubaraka Ibrahim Inaugurates IBD Summit 2026 in Dubai PR Newswire (Press Release) 20:45 Tue, 21 Jul

Johnson & Johnson Lawyer Jumps to Baker McKenzie for Deals Work Bloomberg Law 16:31 Tue, 21 Jul

Stock Watch: Johnson & Johnson Gets No Credit For Weathering The Stelara Cliff Scrip Pharma Intelligence 15:04 Tue, 21 Jul

MedTech Pioneer Max Reinhardt Joins eXeX to Drive Canopus Platform Growth PR Newswire (Press Release) 14:02 Tue, 21 Jul

The Zacks Analyst Blog Highlights Johnson & Johnson, Lam Research, Seagate, KVH Industries and Dawson Geophysical Zacks 09:47 Tue, 21 Jul

Monday

Top Analyst Reports for Johnson & Johnson, Lam Research & Seagate Zacks 22:13 Mon, 20 Jul

Big Pharma And Psychedelic Medicine: Eli Lilly’s $3.8 Billion Bet Forbes 18:00 Mon, 20 Jul

Beyond AI: Why Our Top Dividend Stocks Remain Reliable Picks Kiplinger.com 13:18 Mon, 20 Jul

Sunday

Is It Too Late to Buy Johnson & Johnson After Its Blowout Earnings Report? The Motley Fool 23:22 Sun, 19 Jul

My 2 Favorite Dividend Kings to Buy Right Now The Motley Fool 21:09 Sun, 19 Jul

In the last month

After Disqualifying Beasley Allen, Johnson & Johnson Sets Sights on Other Talc Lawyers Law.com 00:29 Sat, 18 Jul

Johnson & Johnson (JNJ) Stock Faces Margin Squeeze As Q2 Net Profitability Undercuts Bullish Narrative Simply Wall St 22:05 Fri, 17 Jul

Notable Friday Option Activity: XOM, LITE, JNJ Nasdaq 19:44 Fri, 17 Jul

Johnson & Johnson to spend up to $750m restructuring pharmaceutical supply chain Manufacturing Chemist 14:28 Fri, 17 Jul

How Affirmed Talc Successor Liability At Kenvue (KVUE) Has Changed Its Investment Story Simply Wall St 10:04 Fri, 17 Jul

Advertisement

Advertisement

About our Johnson & Johnson news

Latest news on Johnson & Johnson, the American multinational pharmaceutical, known for developing healthcare, pharmaceuticals, and consumer products. Stay updated on stories about their pioneering medical advancements, including vaccines, treatments, and medical devices. Explore insights into the company’s financial performance, share prices, leadership changes, and global strategies.

NewsNow

Our Sites

NewsNow Nigeria

NewsNow România

NewsNow Australia

Work with us

Publisher Network

Dockside Online IDE

Legal

Subscription Terms

© Copyright 1997 - 2026 NewsNow Publishing Limited. All rights reserved.

Back to Business Pharmaceuticals
- Abbott Laboratories
- AbbVie AbbVie
- AstraZeneca
- Baxter Baxter
- Bayer Bayer
- Boehringer Ingelheim
- Bristol Myers Squibb
- Eli Lilly Eli Lilly
- Genentech Genentech
- GlaxoSmithKline
- Johnson and Johnson
- Merck and Co
- Novartis Novartis
- Novavax Novavax
- Novo Nordisk
- Pfizer Pfizer
- Roche Roche
- Sanofi Sanofi
- Takeda Takeda
- Teva Teva
- Zoetis Zoetis